These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29539609)

  • 1. Impaired Secretion of Glucagon-Like Peptide 1 in Patients with Colorectal Adenoma after an Oral Glucose Load.
    Sasaki Y; Abe Y; Takeda H; Nishise S; Yaoita T; Yagi M; Sakuta K; Mizumoto N; Shoji M; Onozato Y; Kawata S; Ueno Y
    Digestion; 2018; 97(4):324-332. PubMed ID: 29539609
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The changes of gastrointestinal hormones GLP-1, PYY and ghrelin in patients with newly diagnosed type 2 diabetes mellitus].
    Cui T; Ren Y; Ma H; Liu SF; Zhang XX; Yu HL
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2013 Sep; 44(5):774-8. PubMed ID: 24325110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired secretion of glucagon-like peptide 1 during oral glucose tolerance test in patients with newly diagnosed type 2 diabetes mellitus.
    Wang XL; Ye F; Li J; Zhu LY; Feng G; Chang XY; Sun K
    Saudi Med J; 2016 Jan; 37(1):48-54. PubMed ID: 26739974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired beta cell sensitivity to incretins in type 2 diabetes is insufficiently compensated by higher incretin response.
    Tura A; Bagger JI; Ferrannini E; Holst JJ; Knop FK; Vilsbøll T; Mari A
    Nutr Metab Cardiovasc Dis; 2017 Dec; 27(12):1123-1129. PubMed ID: 29162361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 secretion in women with gestational diabetes mellitus during and after pregnancy.
    Lencioni C; Resi V; Romero F; Lupi R; Volpe L; Bertolotto A; Ghio A; Del Prato S; Marchetti P; Di Cianni G
    J Endocrinol Invest; 2011 Oct; 34(9):e287-90. PubMed ID: 21666414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patients With Long-QT Syndrome Caused by Impaired
    Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
    Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incretin secretion in relation to meal size and body weight in healthy subjects and people with type 1 and type 2 diabetes mellitus.
    Vilsbøll T; Krarup T; Sonne J; Madsbad S; Vølund A; Juul AG; Holst JJ
    J Clin Endocrinol Metab; 2003 Jun; 88(6):2706-13. PubMed ID: 12788877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The incretin effect in cats: comparison between oral glucose, lipids, and amino acids.
    Gilor C; Graves TK; Gilor S; Ridge TK; Weng HY; Dossin O
    Domest Anim Endocrinol; 2011 May; 40(4):205-12. PubMed ID: 21397435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between metabolic syndrome and meal-induced glucagon like peptide-1 response in type 1 diabetic patients1-1.
    Blaslov K; Bulum T; Zibar K; Duvnjak L
    J Diabetes; 2015 May; 7(3):340-6. PubMed ID: 25042812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromanol 293B, an inhibitor of KCNQ1 channels, enhances glucose-stimulated insulin secretion and increases glucagon-like peptide-1 level in mice.
    Liu L; Wang F; Lu H; Ren X; Zou J
    Islets; 2014; 6(4):e962386. PubMed ID: 25437377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impaired incretin-induced amplification of insulin secretion after glucose homeostatic dysregulation in healthy subjects.
    Hansen KB; Vilsbøll T; Bagger JI; Holst JJ; Knop FK
    J Clin Endocrinol Metab; 2012 Apr; 97(4):1363-70. PubMed ID: 22319034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperinsulinemia, insulin resistance and colorectal adenomas: A meta-analysis.
    Yoon YS; Keum N; Zhang X; Cho E; Giovannucci EL
    Metabolism; 2015 Oct; 64(10):1324-33. PubMed ID: 26169471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta and alpha cell function in metabolically healthy but obese subjects: relationship with entero-insular axis.
    Calanna S; Piro S; Di Pino A; Maria Zagami R; Urbano F; Purrello F; Maria Rabuazzo A
    Obesity (Silver Spring); 2013 Feb; 21(2):320-5. PubMed ID: 23404781
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impaired circulating glucagon-like peptide-1 response to oral glucose in women with previous gestational diabetes.
    Forbes S; Moonan M; Robinson S; Anyaoku V; Patterson M; Murphy KG; Ghatei MA; Bloom SR; Johnston DG
    Clin Endocrinol (Oxf); 2005 Jan; 62(1):51-5. PubMed ID: 15638870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Addition of metformin to exogenous glucagon-like peptide-1 results in increased serum glucagon-like peptide-1 concentrations and greater glucose lowering in type 2 diabetes mellitus.
    Cuthbertson J; Patterson S; O'Harte FP; Bell PM
    Metabolism; 2011 Jan; 60(1):52-6. PubMed ID: 20152998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
    Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
    Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of short-term continuous subcutaneous insulin infusion treatment on fasting glucagon-like peptide-1 concentrations in newly diagnosed type 2 diabetes.
    Huang X; Li S; Yang M; Fu X; Li H; Yan T; Liu Y; Chen L; Lan L; Li L; Zhong X
    Diabetes Res Clin Pract; 2018 Apr; 138():246-252. PubMed ID: 29408704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
    Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
    Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced GLP-1 Secretion at 30 Minutes After a 75-g Oral Glucose Load Is Observed in Gestational Diabetes Mellitus: A Prospective Cohort Study.
    Sukumar N; Bagias C; Goljan I; Weldeselassie Y; Gharanei S; Tan BK; Holst JJ; Saravanan P
    Diabetes; 2018 Dec; 67(12):2650-2656. PubMed ID: 30232211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired secretion of active GLP-1 in patients with hypertriglyceridaemia: A novel lipotoxicity paradigm?
    Wang X; Liu J; Li C; Zhao M; Liu L; Guan Q; Zhang H; Zhang X; Gao L; Zhao J; Song Y
    Diabetes Metab Res Rev; 2018 Feb; 34(2):. PubMed ID: 29135069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.